Evidence map›Paper›PMID 35670620›Full record

ArticleMicrobiology spectrum2022

Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia.

G Günther, E Saathoff, A Rachow, H Ekandjo, A Diergaardt, N Marais, C Lange, E Nepolo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

G GüntherDepartment of Pulmonology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-2217-4322
E SaathoffDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
A RachowDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
H EkandjoDepartment of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
A DiergaardtDepartment of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
N MaraisDepartment of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
C Lange *Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
E Nepolo *Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
University of Namibia · NALMU Klinikum · DEBaylor College of Medicine · USUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of tuberculosis requires rapid information about Mycobacterium tuberculosis (

Indexed as

Mycobacterium tuberculosisTuberculosis, Lymph NodeTuberculosis, Multidrug-ResistantDrug ResistanceDrug Resistance, BacterialFluoroquinolonesHumansIsoniazidNamibiaRifampinFluoroquinolonesIsoniazidRifampindiagnosticsmulti-drug resistantmycobacterium tuberculosismycobacterium tuberculosis detectionsecond-line resistanceXpert MTB/RIF

Identifiers

PMID35670620
PMCPMC9241941
OpenAlexW4282034858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.